ESBL-producing bacteria can lead to severe infections such as urinary tract infections, bloodstream infections, and pneumonia. These infections are more challenging to treat and often require the use of more potent, broad-spectrum antibiotics, which can have more severe side effects. The presence of ESBLs also necessitates more stringent infection control measures to prevent the spread of these resistant organisms.
